SCHEMBL13367472

SCHEMBL13367472

c1ccc(Nc2cc3ccccc3c3ccccc23)nc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.58
MEN1 O00255 6/20 0.58
MAPK10 P53779 1/20 0.58
GFER P55789 1/20 0.58
APAF1 O14727 1/20 0.54
TDP2 O95551 1/20 0.54
CDC25B P30305 1/20 0.54
CASP6 P55212 1/20 0.54
RCE1 Q9Y256 1/20 0.54
ACP1 P24666 1/20 0.48
KDM4E B2RXH2 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
ALOX12 P18054 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPC1 O15118 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5779584 0.82 MEN1 (0.53) KMT2AMEN1MAPK10GFERAPAF1
SCHEMBL16760997 0.79 ALDH1A1 (0.57) KMT2AMEN1CDC25BKDM4ESMN1; SMN2
SCHEMBL5775081 0.79 APAF1 (0.56) KMT2AMEN1MAPK10GFERAPAF1
SCHEMBL904435 0.79 KMT2A (0.68) KMT2AMEN1MAPK10GFERAPAF1
SCHEMBL5776205 0.78 KMT2A (0.61) KMT2AMEN1MAPK10GFERAPAF1
SCHEMBL3279571 0.75 MEN1 (1.00) KMT2AMEN1MAPK10GFERSMN1; SMN2
SCHEMBL6175579 0.74 KMT2A (0.73) KMT2AMEN1MAPK10GFERKDM4E
SCHEMBL5914015 0.73 KMT2A (0.55) KMT2AMEN1MAPK10GFERAPAF1
SCHEMBL5770714 0.73 KMT2A (0.50) KMT2AMEN1MAPK10GFERAPAF1
SCHEMBL5914177 0.72 KMT2A (0.53) KMT2AMEN1MAPK10GFERAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 KMT2A 3622/4885MEN1 3828/4885MAPK10 1546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.